225430 Stock Chart & Stats
₩1800.00
₩45.00(2.56%)
―
--
Day’s Range― - ―
52-Week Range₩1,099.00 - ₩6,850.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)112.60K
Market Cap
₩9.79B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,577,410
10 Day Avg. Volume85,599
30 Day Avg. Volume112,602
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
225430 FAQ
What was KMPHARMACEUTICAL Co., Ltd.’s price range in the past 12 months?
KMPHARMACEUTICAL Co., Ltd. lowest stock price was ₩1099.00 and its highest was ₩6850.00 in the past 12 months.
What is KMPHARMACEUTICAL Co., Ltd.’s market cap?
KMPHARMACEUTICAL Co., Ltd.’s market cap is ₩9.79B.
When is KMPHARMACEUTICAL Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were KMPHARMACEUTICAL Co., Ltd.’s earnings last quarter?
KMPHARMACEUTICAL Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩149.56 earnings per share for the quarter, missing the consensus estimate of N/A by -₩149.56.
Is KMPHARMACEUTICAL Co., Ltd. overvalued?
According to Wall Street analysts KMPHARMACEUTICAL Co., Ltd.’s price is currently Undervalued.
Does KMPHARMACEUTICAL Co., Ltd. pay dividends?
KMPHARMACEUTICAL Co., Ltd. does not currently pay dividends.
What is KMPHARMACEUTICAL Co., Ltd.’s EPS estimate?
KMPHARMACEUTICAL Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KMPHARMACEUTICAL Co., Ltd. have?
KMPHARMACEUTICAL Co., Ltd. has 5,577,410 shares outstanding.
What happened to KMPHARMACEUTICAL Co., Ltd.’s price movement after its last earnings report?
KMPHARMACEUTICAL Co., Ltd. reported an EPS of -₩149.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of KMPHARMACEUTICAL Co., Ltd.?
Currently, no hedge funds are holding shares in KR:225430
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aprogen, Inc
―
TELCON RF PHARMACEUTICAL. Inc.
―
SD Biotechnologies Co., Ltd.
―
OliPass Corp.
―
From Bio Co., Ltd.
―